Medical Xpress

JANUARY 18, 2025

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky fewin this case, children, adolescents, and young adults. Because its symptoms can vary from person to person, it's often missed or misdiagnosed until it has metastasized and becomes lethal. Moreover, drug therapies for common liver cancers are not just useless for FLC patients but actually harmful.

Clinical Trials 92

Clinical Trials Clinical Trials Trials Drugs 92

pharmaphorum

JANUARY 18, 2025

Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt it has just filed a lawsuit seeking to block the deal

105

105

Medical Xpress

JANUARY 18, 2025

Researchers at Baylor College of Medicine and collaborating institutions have improved our understanding of how rotavirus, the most common cause of acute gastroenteritis in children, makes people sick. The study published in Science Advances is among the first to show that the rotavirus protein NSP4 is both necessary and sufficient for multiple aspects of rotavirus infection by disrupting calcium signaling not only within infected cells but also in nearby uninfected cells.

Protein 83

Protein Medicine Research 83

pharmaphorum

JANUARY 18, 2025

Can a new FDA approval in colorectal cancer kickstart sales growth for Amgen's KRAS inhibitor Lumakras

FDA Approval 95

FDA Approval Sales Drugs 95

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Medical Xpress

JANUARY 18, 2025

Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ischemic stroke, only about 5 percent fully recover. Most others suffer from long-term problems, including weakness, chronic pain, or epilepsy.

126

126

pharmaphorum

JANUARY 18, 2025

Can a new FDA approval in colorectal cancer kickstart sales growth for Amgen's KRAS inhibitor Lumakras

FDA Approval 59

FDA Approval Sales Drugs 59

pharmaphorum

JANUARY 18, 2025

AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate for breast cancer - TROP2-directed Datroway.

FDA Approval 59

FDA Approval Antibody Drugs 59

Medical Xpress

JANUARY 18, 2025

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH). To address this, CVD prevention plans rely on prediction models like atherosclerotic cardiovascular disease (ASCVD) risk scores to estimate the risk of heart disease.

76

76